Skip to main content
GutCited

Management of irritable bowel syndrome.

A Prior, P J Whorwell
Other Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 1986 4 citas
PubMed
<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'pmid\u003D3011142'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Tipo de estudio
Controlled Clinical Trial
Población
IBS patients
Intervención
Management of irritable bowel syndrome. None
Comparador
None
Resultado primario
pain
Dirección del efecto
Positive
Riesgo de sesgo
Moderate

Abstract

Few drugs are of proven efficacy in irritable bowel syndrome. Bulking agents probably relieve constipation, spasmolytics may alleviate pain and antidiarrhoeals help control urgency and diarrhoea. With a combination of reassurance and therapeutic intervention up to 75% of patients can be expected to improve. For the 25% who do not, alternative therapies such as stress management, psychotherapy or hypnotherapy may prove effective.

TL;DR

With a combination of reassurance and therapeutic intervention up to 75% of patients can be expected to improve, and alternative therapies such as stress management, psychotherapy or hypnotherapy may prove effective.

Used In Evidence Reviews

Similar Papers